FLCCC Alliance Calls on National HealthAuthorities to Immediately Review Medical Evidence Showing the Efficacy of Ivermectin for the Prevention of COVID-19 and as an Early Outpatient Treatment

Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

Newswise — “Following the swift review— and subsequent guidance— by the NIH and the CDC of Ivermectin, we expect that Ivermectin’s widespread, immediate use will allow for a rapid and safe re-opening of businesses and schools across the nation—and quickly reduce the strain on overwhelmed ICUs.” —FLCCC Alliance

HOUSTON, TEXAS—DECEMBER 4, 2020:—At a press conference on Friday at United Memorial Medical Center in Houston, Texas, three Critical Care physician/ scholars from the Frontline COVID-19 Critical Care Alliance (FLCCC), developers of the MATH+ Hospital Treatment Protocol for COVID-19, presented comprehensive scientific evidence—including Randomized Controlled Trials (RCTs) and Observational Controlled Trials—demonstrating that Ivermectin, a key component of the FLCCC’s I-MASK+ Prophylaxis and Early Outpatient Treatment Protocol, is the potential solution to the unprecedented global surge of the COVID-19 pandemic.

The FLCCC Alliance also said that widespread use of this protocol would contribute to a rapidand safe re-opening of businesses and schools across the na+on—and reduce the current strain on overwhelmed hospitals and ICUs.

“The effective vaccines for which we have all been waiting are coming very soon, but not soon enough to save the tens of thousands who are projected to die before the wide spread distribution of the vaccines can be completed,” said Dr. Pierre Kory, a founding member of the FLCCC Alliance, an Associate Professor of Medicine and Critical Care physician at St. Luke’s Medical Center in Milwaukee, Wisconsin. Right now, COVID-19 is a runaway train barreling down the tracks, and if you’re on those tracks, Ivermectin can help lift you out of harm’s way.”

Over the last several weeks, the Critical Care physicians of the FLCCC Alliance conducted acomprehensive review of the rapidly emerging scientific evidence on Ivermectin from studies conducted around the world. (The link to their review is HERE.) This review led the team to develop the I-Mask+ Protocol and to call for its urgent adoption by health authorities — whocould subsequently issue immediate guidance for the nation’s prescribing physicians.

“It is true that these rapidly emerging studies demonstrate the power of Ivermectin, are purposed, 40-year-old drug first approved by the World Health Organization (WHO) for treating parasitic infections,” said Dr. Paul Marik, the founder of the FLCCC Alliance, Professor of Medicine and the most highly published Critical Care physician in America. “Furthermore, overthe last four decades, Ivermectin has been used safely by 3.7 billion people.

“Why it works so well in COVID-19 is that Ivermectin has shown very high activity fighting both the SARS-CoV-2 virus as well as the inflammation produced in all stages of COVID-19. It works pre-and post-exposure, the early symptoms phase and late-stage disease,” continued Dr. Marik. “New and highly compelling data has emerged since August—which is the last time the National Institutes of Health (NIH) reviewed or updated their data. We now know from numerous and increasing randomized controlled trials that Ivermectin inhibits the SARS virus and prevents the virus from multiplying. Study after study shows consistent and reproducible efficacy."

The FLCCC Alliance physicians believe that Ivermectin is the potential solution to the pandemic— and will change the face of this disease worldwide. That is why the FLCCC is calling upon national health authorities to swiftly review the comprehensive medical evidence and issue guidelines for doctors to begin immediately prescribing Ivermectin for their patients.

“If the goal is to prevent people from getting COVID-19 and to keep people in the early phase of the disease from ever progressing to serious illness, then we have just the treatment,” said Dr.Joe Varon, Chief of Staff and Chie of Critical Care Services at United Memorial Medical Center in Houston, who has been taking care of critically ill COVID-19 patients for 280 consecutive days.“It is also part of a combination that doctors throughout the nation can safely prescribe. It is inexpensive, off-patent, and widely available around the globe. And with continued mask wearing,social distancing and hand-washing, it can get this nation back to work—well beforethe widespread distribution of the vaccine.”

The components in the FLCCC’s I-Mask+ Protocol can also reduce the current out-of-control hospitalizations. Epidemiological data from all over the world show that with Ivermectin, infection rates and death rates are plummeting. (Link to protocol is HERE.)

“We find it that these data are consistent and credible,” said Dr. Kory. “More and more studies keep coming in everyday. We are thoroughly convinced that this is the potential solution to the global pandemic.”

Many patients who have already asked their doctors to prescribe Ivermectin for them have been turned away. “Ignoring the data and the findings supporting Ivermectin in the treatment of COVID19 is an abandonment of the Hippocratic oath,” said Dr. Marik.

The FLCCC Alliance’s comprehensive “Guide to the Management of COVID-19” can be accessed HERE.

The entire Electronic Press Kit can be accessed at FLCCC.net.

                                                                                                 ###

Additional Info

Drs. Varon, Marik, and Kory are founding members of the Frontline COVID-19 Critical Care Alliance (FLCCC)a 501(c)(3) nonprofit organization formed by a group of Critical Care physician/scholars — with the academic support of allied physicians from around the world — formed in March 2020, to research and develop life saving protocols for the prevention and treatment of COVID-19 in all stages of illness. The FLCCC doctors share decades of experience in hospital ICUs and have published more than 1,000 scientific studies in leading medical journals. (The FLCCC is not associated in any way with the group called ‘America’s Frontline Doctors’.)

If you want to know more about the FLCCC Alliance please regard our “About” section on www.flccc.net, in particular the “FLCCC Alliance Story.”

In addition our home page contains Scientific Reviews and many links to scientific studies that provide the medical evidence in support of our prophylaxis & treatment protocols for Covid-19.

FLCCC Alliance – Mission Statement and Objectives

Formed by leading critical care specialists in March 2020, at the beginning of the Coronavirus pandemic, the ‘Front Line COVID-19 Critical Care Alliance’ is now a 501(c)(3) non-profit organization dedicated to developing highly effective treatment protocols to prevent the transmission of COVID-19 and to improve the outcomes for patients ill with the disease.

We are dedicated to

− Reviewing all emerging published medical literature on COVID-19 from in-vitro, animal, clinical, and epidemiologic studies.

− Developing effective treatment protocols for COVID-19 that evolve by incorporating newly identified, applicable therapeutic and pathophysiologic insights.

− Educating physicians on safe and effective treatment approaches to all phases of COVID-19, fromdisease prevention strategies to the use of our combination-based therapy protocols in both early stage (I-MASK+) and hospitalized patients (MATH+).

− Improving outcomes for people impacted by COVID-19 disorders through preventive and treatment strategies designed to optimize health.

− Teaching the public ways to prevent transmission of the virus and to advocate for the best possible care.

− Coordinating and accelerating the formation of research studies that will support effective prevention and therapeutic treatments for all impacted by COVID-19

We accomplish these goals by sponsoring high quality medical education for both the public and health care providers, via the publication of scientific manuscripts, media interviews, and medical lectures for medical providers and the public.

 




Filters close

Showing results

110 of 5640
Released: 15-May-2021 8:05 AM EDT
Rutgers Reports First Instance of COVID-19 Triggering Recurrent Blood Clots in Arms
Rutgers University-New Brunswick

Researchers at Rutgers Robert Wood Johnson Medical School are reporting the first instance of COVID-19 triggering a rare recurrence of potentially serious blood clots in people’s arms.

access_time Embargo lifts in 2 days
Embargo will expire: 20-May-2021 10:00 AM EDT Released to reporters: 14-May-2021 2:40 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-May-2021 10:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 14-May-2021 11:25 AM EDT
Access to overdose-reversing drugs declined during pandemic, researchers find
Beth Israel Lahey Health

In a new study, clinician-researchers at Beth Israel Deaconess Medical Center (BIDMC) analyzed naloxone prescription trends during the COVID-19 pandemic in the United States and compared them to trends in opioid prescriptions and to overall prescriptions.

Released: 14-May-2021 11:00 AM EDT
No Excuses: Stop Procrastinating on These Key Health Checks
Michigan Medicine - University of Michigan

A quick guide to the most-valuable preventive care that adults need to get scheduled, to catch up on what they may have missed during the height of the pandemic, and to address issues that the pandemic might have worsened.

Released: 13-May-2021 7:05 PM EDT
FLCCC Statement on the Irregular Actions of Public Health Agencies & the Disinformation Campaign Against Ivermectin
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

FLCCC Alliance calls for whistleblower to step forward from within WHO, the FDA, the NIH, Merck, or Unitaid to counter this misrepresentation

Newswise: shutterstock_1724336896.jpg
Released: 13-May-2021 12:55 PM EDT
Kreuter receives $1.9 million in grants to increase vaccinations in St. Louis
Washington University in St. Louis

Matthew Kreuter, the Kahn Family Professor of Public Health at the Brown School, has received $1.9 million in grants to help increase COVID-19 vaccinations among Blacks in St. Louis City and County.

Released: 13-May-2021 11:35 AM EDT
COVID-19 mRNA Vaccines are Immunogenic in Pregnant and Lactating Women, Including Against Viral Variants
Beth Israel Deaconess Medical Center

In a new study from Beth Israel Deaconess Medical Center researchers evaluated the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women who received either the Pfizer or Moderna COVID-19 vaccines. They found that both vaccines triggered immune responses in pregnant and lactating women.

Released: 13-May-2021 10:30 AM EDT
Pandemic stigma: Foreigners, doctors wrongly targeted for COVID-19 spread in India
Monash University

The Indian public blamed foreigners, minority groups and doctors for the rapid spread of COVID-19 across the country during the first wave, due to misinformation, rumour and long-held discriminatory beliefs, according to an international study led by Monash University.


Showing results

110 of 5640

close
1.28066